Chronic obstructive pulmonary disease and Neoplasm progression
Summary:
Neoplasm progression is found among people with Chronic obstructive pulmonary disease, especially for people who are male, 60+ old.
The study analyzes which people have Neoplasm progression with Chronic obstructive pulmonary disease. It is created by eHealthMe based on reports of 62 people who have Chronic obstructive pulmonary disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,803 drugs and 2,209 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.
What is Neoplasm progression?
Neoplasm progression (growth of tumour) is found to be associated with 1,067 drugs and 915 conditions by eHealthMe. Check the latest studies of Neoplasm progression.
62 people who have Chronic Obstructive Pulmonary Disease and Neoplasm Progression are studied.

Gender of people who have Chronic Obstructive Pulmonary Disease and experienced Neoplasm Progression *:
- female: 48.39 %
- male: 51.61 %
Age of people who have Chronic Obstructive Pulmonary Disease and experienced Neoplasm Progression *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 1.79 %
- 50-59: 16.07 %
- 60+: 82.14 %
Common co-existing conditions for these people *:
- Pain: 19 people, 30.65%
- High Blood Pressure: 14 people, 22.58%
- Depression: 12 people, 19.35%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 14.52%
- Stress And Anxiety: 8 people, 12.90%
- Breast Cancer Metastatic: 8 people, 12.90%
- Asthma: 6 people, 9.68%
- High Blood Cholesterol: 5 people, 8.06%
- Lung Cancer - Non-Small Cell (lung cancer): 5 people, 8.06%
- Indigestion: 5 people, 8.06%
Common drugs taken by these people *:
- Spiriva: 20 people, 32.26%
- Ibrance: 11 people, 17.74%
- Proair Hfa: 6 people, 9.68%
- Symbicort: 6 people, 9.68%
- Ventolin: 5 people, 8.06%
- Breo Ellipta: 5 people, 8.06%
- Stiolto Respimat: 5 people, 8.06%
- Sutent: 5 people, 8.06%
- Oxycodone: 5 people, 8.06%
- Albuterol: 5 people, 8.06%
Common symptoms for these people *:
- Lung Neoplasm Malignant (cancer tumour of lung): 10 people, 16.13%
- Fatigue (feeling of tiredness): 7 people, 11.29%
- Diarrhea: 7 people, 11.29%
- Dyspnea (difficult or laboured breathing): 6 people, 9.68%
- Weakness: 6 people, 9.68%
- Nausea (feeling of having an urge to vomit): 6 people, 9.68%
- Pneumonia: 6 people, 9.68%
- Death: 5 people, 8.06%
- Joint Pain: 5 people, 8.06%
- Malaise (a feeling of general discomfort or uneasiness): 5 people, 8.06%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Neoplasm progression?
- Check whether Neoplasm progression is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Chronic obstructive pulmonary disease (198,253 reports)
- Neoplasm progression (41,778 reports)
All the drugs that are associated with Neoplasm progression:
- Neoplasm progression (1,067 drugs)
All the conditions that are associated with Neoplasm progression:
- Neoplasm progression (915 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Neoplasm progression and Chronic obstructive pulmonary disease, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pepcid cause Oxygen Saturation Decreased? - 2 seconds ago
- Drug interactions of Nplate and Cytoxan - 9 seconds ago
- Could Ancef cause Local Swelling? - 12 seconds ago
- Lamictal and Abnormal Dreams for Men aged 50-59 - 13 seconds ago
- Herpes Simplex and drugs of ingredients of docosanol - 21 seconds ago
- Drug interactions of Meloxicam and Primidone - 24 seconds ago
- Could Coreg cause Plasmacytoma? - 32 seconds ago
- Systemic Lupus Erythematosus and Lump In The Abdomen - 39 seconds ago
- Ritalin and Red Face for Women aged 50-59 - 41 seconds ago
- Drug interactions of Prezista and Losartan - 41 seconds ago